Atlas Trials

A Cross-over Study of OligoG in Subjects With Cystic Fibrosis. Fibrosis

Clinical trial NCT01465529 · COMPLETED

Trial details

NCT number
NCT01465529
Sponsor
AlgiPharma AS
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Cystic Fibrosis
Start date
2011-05-01
Primary completion
2013-10-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.